Marije E. Weidema

Nijmegen, GE 6525GA, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Author Correction: Establishment and characterization of the first patient-derived radiation-induced angiosarcoma xenograft model (RT-AS5).

Author Correction: Establishment and characterization of the first patient-derived radiation-induced angiosarcoma xenograft model (RT-AS5).

Journal: Scientific reports

Published: July 10, 2025

Prognostic Factors in Epithelioid Hemangioendothelioma: Analysis of a Nationwide Molecularly/Immunohistochemically Confirmed Cohort of 57 Cases.

Prognostic Factors in Epithelioid Hemangioendothelioma: Analysis of a Nationwide Molecularly/Immunohistochemically Confirmed Cohort of 57 Cases.

Journal: Cancers

Published: June 01, 2023

Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma Subgroups.

Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma Subgroups.

Journal: Cancers

Published: October 27, 2022

Establishment and characterization of the first patient-derived radiation-induced angiosarcoma xenograft model (RT-AS5).

Establishment and characterization of the first patient-derived radiation-induced angiosarcoma xenograft model (RT-AS5).

Journal: Scientific reports

Published: September 16, 2022

Setting the international research agenda for sarcoma together with patients and carers: first results of the Sarcoma Patient EuroNet (SPAEN) priority setting partnership.

Setting the international research agenda for sarcoma together with patients and carers: first results of the Sarcoma Patient EuroNet (SPAEN) priority setting partnership.

Journal: ESMO open

Published: April 06, 2022

Analysis of PD-1, PD-L1, and T-cell infiltration in angiosarcoma pathogenetic subgroups.

Analysis of PD-1, PD-L1, and T-cell infiltration in angiosarcoma pathogenetic subgroups.

Journal: Immunologic research

Published: May 20, 2021

PARP inhibition in UV-associated angiosarcoma preclinical models.

PARP inhibition in UV-associated angiosarcoma preclinical models.

Journal: Journal of cancer research and clinical oncology

Published: April 17, 2021

Supportive care needs of patients living with an extremely rare and unpredictable cancer: The Epithelioid Haemangioendothelioma patient experience.

Supportive care needs of patients living with an extremely rare and unpredictable cancer: The Epithelioid Haemangioendothelioma patient experience.

Journal: European journal of cancer care

Published: February 27, 2021

Health-related quality of life and symptom burden of epithelioid hemangioendothelioma patients: a global patient-driven Facebook study in a very rare malignancy.

Health-related quality of life and symptom burden of epithelioid hemangioendothelioma patients: a global patient-driven Facebook study in a very rare malignancy.

Journal: Acta oncologica (Stockholm, Sweden)

Published: June 02, 2020

Sarcoma classification by DNA methylation profiling.

Sarcoma classification by DNA methylation profiling.

Journal: Nature communications

Published: March 23, 2020

Prognostic Factors in a Large Nationwide Cohort of Histologically Confirmed Primary and Secondary Angiosarcomas.

Prognostic Factors in a Large Nationwide Cohort of Histologically Confirmed Primary and Secondary Angiosarcomas.

Journal: Cancers

Published: October 16, 2019

The heterogeneity of Epithelioid Hemangioendothelioma (EHE): A case series and review of the literature with emphasis on treatment options.

The heterogeneity of Epithelioid Hemangioendothelioma (EHE): A case series and review of the literature with emphasis on treatment options.

Journal: Seminars in oncology

Published: August 16, 2019

Showing 1-12 of 17

Last Updated: 09/26/2026